CompletedNot Applicable

High-Purity Type I Collagen Augmentation in Meniscal Repair

India18 participantsStarted 2026-01-03

Plain-language summary

This prospective, single-arm feasibility study evaluates the safety, procedural feasibility, and early clinical outcomes of High-Purity Type I Collagen used as an adjunct in arthroscopic meniscal repair. The study aims to generate preliminary clinical, functional, and imaging data to inform the design of a future randomized controlled trial.

Who can participate

Age range18 Years – 55 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Age 18 to 55 years * Symptomatic meniscal tear confirmed on MRI and indicated for arthroscopic repair * Tear patterns amenable to repair * Stable knee or concomitant ACL reconstruction permitted * Ability to comply with rehabilitation and follow-up * Written informed consent provided Exclusion Criteria: * Advanced knee osteoarthritis (Kellgren-Lawrence grade ≥3) * Irreparable meniscal tears requiring meniscectomy * Active joint infection or inflammatory arthritis * Prior surgical repair of the index meniscus * Known hypersensitivity to collagen products * Systemic conditions impairing wound healing

What they're measuring

Safety of High-Purity Type I Collagen Augmentation

Timeframe: From surgery to 2 months post-operatively

Trial details

NCT IDNCT07352410

SponsorAdichunchanagiri Institute of Medical Sciences, B G Nagara

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-03-05

Results submitted2026-03-10

View on ClinicalTrials.gov More Meniscus Tear trials